This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

Correlates of Prescription Opioid Use, Misuse, Use Disorders, and Motivations for Misuse Among US Adults

Beth Han, MD, PhD, MPH; Wilson M. Compton, MD, MPE; Carlos Blanco, MD, PhD; and Christopher M. Jones, PharmD, MPH

Published: August 14, 2018

Article Abstract

Objective: To simultaneously examine characteristics associated with prescription opioid use, misuse, and use disorders among US adults and assess correlates of their motivations for prescription opioid misuse.

Methods: Data were examined from 51,200 adults 18 years or older who participated in the 2015 National Survey on Drug Use and Health. Prescription opioid use disorders were based on DSM-IV criteria. Bivariable and multivariable multinomial logistic regressions were applied.

Results: Prescription opioid use disorders were associated with ages 18-29 and 30-49 years, male sex, good/fair/poor health, suicidal ideation, and tobacco use, alcohol or cocaine use disorders, heroin use or use disorders, and other psychotropic medication misuse or use disorders. Among US adult prescription opioid misusers, 63.4% reported that the main motivation for their most recent misuse was to relieve physical pain, followed by seeking to get high (11.6%) or to relax (10.9%). Sociodemographic characteristics, mental illness, and specific substance use and use disorders were associated with specific motivations for misusing prescription opioids. Among adults with prescription opioid use, reporting pain relief as a motivation for prescription opioid misuse was associated with suicidal ideation, cannabis and heroin use or use disorders, cocaine use disorders, and other psychotropic misuse or use disorders.

Conclusions: Our results suggest that clinicians should assess prescription opioid misuse and its motivations and screen for multiple co-occurring behavioral health conditions in patients who misuse prescription opioids.

Volume: 79

Quick Links: Addiction , Substance Use Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...